Human epidermal growth factor receptor 2

Human epidermal growth factor receptor 2 (HER2) has been identified as a molecular target for breast cancer therapy, such as Trastuzumab (Herceptin®). This has been shown to improve patient survival substantially.

10p vibego 02-02-2024 7 0   Download

Bài viết Khảo sát ảnh hưởng của thời gian thiếu máu lạnh lên sự biểu hiện của các dấu ấn ER, PR và HER-2 trong ung thư vú bằng kỹ thuật nhuộm hóa mô miễn dịch trình bày khảo sát sự ảnh hưởng của các mốc thời gian thiếu máu lạnh lên sự biểu hiện của các dấu ấn ER, PR và Her-2.

8p vidumbledore 06-01-2023 13 5   Download

We investigated the clinicopathological characteristics and survival of breast cancer lung metastases (BCLM) patients at initial diagnosis of metastatic breast cancer (MBC) in the Han population.

9p vielonmusk 21-01-2022 11 2   Download

To investigate the prognostic value of derived neutrophil to lymphocyte ratio (dNLR) and lactate dehydrogenase (LDH) in patients with advanced HER2 positive breast cancer treated with trastuzumab emtansine.

13p vielonmusk 21-01-2022 18 1   Download

Trastuzumab and fulvestrant combination therapy is one of the treatment options for patients with hormone receptor- and human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer; however, there are limited studies evaluating the efficacy of this combination therapy.

7p vielonmusk 21-01-2022 18 1   Download

Human airway trypsin-like protease (HAT), a serine protease found in the sputum of patients with chronic airway diseases, is an agonist of protease-activated receptor-2 (PAR-2). Previous results have shown that HAT enhances the release of amphiregulin (AR); further, it causes MUC5AC gene expression through the AR-epidermal growth factor receptor pathway in the airway epithelial cell line NCI-H292.

13p dell39 27-03-2013 33 1   Download

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Sustained complete remission of human epidermal growth factor receptor 2-positive metastatic breast cancer in the liver during long-term trastuzumab (Herceptin) maintenance therapy in a woman: a case report

4p toshiba25 09-12-2011 61 3   Download